These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6377481)

  • 1. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
    Hoffmann S
    Scand J Plast Reconstr Surg; 1984; 18(1):119-26. PubMed ID: 6377481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Silver sulfadiazine (Flamazine). An antibacterial agent in the local prevention and therapy of burn wound infections].
    Hoffmann S
    Ugeskr Laeger; 1984 Jul; 146(30):2250-2. PubMed ID: 6515819
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
    Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S
    J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical chemotherapy for burns using cerium salts and silver sulfadiazine.
    Fox CL; Monafo WW; Ayvazian VH; Skinner AM; Modak S; Stanford J; Condict C
    Surg Gynecol Obstet; 1977 May; 144(5):668-72. PubMed ID: 850849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds.
    Modak SM; Sampath L; Fox CL
    J Burn Care Rehabil; 1988; 9(4):359-63. PubMed ID: 3146573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
    Modak S; Fox CL
    J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical therapy and the development of silver sulfadiazine.
    Fox CL
    Surg Gynecol Obstet; 1983 Jul; 157(1):82-8. PubMed ID: 6857475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns.
    Wang XW; Wang NZ; Zhang OZ; Zapata-Sirvent RL; Davies JW
    Burns Incl Therm Inj; 1985 Feb; 11(3):197-201. PubMed ID: 3986644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriological effect of cerium-flamazine cream in major burns.
    Boeckx W; Focquet M; Cornelissen M; Nuttin B
    Burns Incl Therm Inj; 1985 Jun; 11(5):337-42. PubMed ID: 4027748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the dosimetry of 1% silver sulfadiazine cream in burn wound treatment.
    Fuller FW; Parrish M; Nance FC
    J Burn Care Rehabil; 1994; 15(3):213-23. PubMed ID: 8056810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).
    Ballin JC
    JAMA; 1974 Nov; 230(8):1184-5. PubMed ID: 4479596
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds.
    Sawhney CP; Sharma RK; Rao KR; Kaushish R
    Burns; 1989 Dec; 15(6):403-6. PubMed ID: 2516445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, excretion and tissue distribution of silver sulphadiazine.
    Sano S; Fujimori R; Takashima M; Itokawa Y
    Burns Incl Therm Inj; 1982 Mar; 8(4):278-85. PubMed ID: 7066727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective analysis of silver sulfadiazine with and without cerium nitrate as a topical agent in the treatment of severely burned children.
    Bowser BH; Caldwell FT; Cone JB; Eisenach KD; Thompson CH
    J Trauma; 1981 Jul; 21(7):558-63. PubMed ID: 7019454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerium nitrate-silver sulfadiazine cream in the treatment of burns: a prospective, randomized study.
    Helvig EI; Munster AM; Su CT; Oppel W
    Am Surg; 1979 Apr; 45(4):270-2. PubMed ID: 434623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of a topical antibacterial agent (silver sulfadiazine) on soft-tissue wounds].
    Bocchiotti G; Robotti E
    Minerva Chir; 1990 May; 45(9):677-81. PubMed ID: 2202932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human pharmacology of silver sulphadiazine (AgSD).
    Fox CL
    Burns Incl Therm Inj; 1985 Apr; 11(4):306-7. PubMed ID: 4005650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.